AEON Biopharma (AEON) News Today → Hurry! Buy this stock before the Robinhood traders do! (From Traders Agency) (Ad) Free AEON Stock Alerts $1.68 +0.04 (+2.44%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31, 2024 | americanbankingnews.comAEON Biopharma (NASDAQ:AEON) Receives Buy Rating from HC WainwrightMay 30, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Rating Reiterated by HC WainwrightHC Wainwright restated a "buy" rating and issued a $6.00 price target on shares of AEON Biopharma in a research report on Thursday.May 29, 2024 | markets.businessinsider.comAEON Biopharma Cuts 55% Of Workforce, Terminates CFO To Preserve Cash; Stock Up In Pre-marketMay 29, 2024 | globenewswire.comAEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction PlanMay 17, 2024 | marketbeat.comAEON Biopharma, Inc. (NASDAQ:AEON) Expected to Earn FY2028 Earnings of $0.18 Per ShareAEON Biopharma, Inc. (NASDAQ:AEON - Free Report) - Investment analysts at HC Wainwright issued their FY2028 EPS estimates for AEON Biopharma in a report issued on Wednesday, May 15th. HC Wainwright analyst D. Tsao anticipates that the company will earn $0.18 per share for the year. HC WainwrightMay 15, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Price Target Cut to $6.00HC Wainwright dropped their target price on AEON Biopharma from $18.00 to $6.00 and set a "buy" rating on the stock in a research report on Wednesday.May 15, 2024 | finance.yahoo.comAEON Biopharma, Inc. (AEON)May 14, 2024 | globenewswire.comAEON Biopharma Reports First Quarter 2024 Financial ResultsMay 9, 2024 | globenewswire.comAEON Biopharma Provides Update on Development PipelineMay 7, 2024 | markets.businessinsider.comMaintaining Buy on AEON Biopharma: Potential of ABP-450 Despite Phase 2 SetbackMay 6, 2024 | marketbeat.comAEON Biopharma's (AEON) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $18.00 price target on shares of AEON Biopharma in a report on Monday.May 3, 2024 | msn.comNewly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here WhyMay 3, 2024 | finance.yahoo.comUS Equity Markets Close Higher Friday Following Weak Jobs ReportMay 3, 2024 | markets.businessinsider.comAEON Says Preliminary Results From Phase 2 Interim Analysis Of ABP-450 Fails To Meet Primary GoalMay 3, 2024 | globenewswire.comAEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic MigraineApril 19, 2024 | marketbeat.comHC Wainwright Analysts Boost Earnings Estimates for AEON Biopharma, Inc. (NASDAQ:AEON)AEON Biopharma, Inc. (NASDAQ:AEON - Free Report) - Stock analysts at HC Wainwright upped their Q1 2024 earnings per share (EPS) estimates for AEON Biopharma in a report issued on Wednesday, April 17th. HC Wainwright analyst D. Tsao now expects that the company will earn ($0.31) per share for theApril 18, 2024 | markets.businessinsider.comAEON Biopharma: Buoyant Prospects Following FDA Alignment on Migraine StudiesApril 18, 2024 | marketbeat.comAEON Biopharma, Inc. Forecasted to Earn Q1 2025 Earnings of ($0.29) Per Share (NASDAQ:AEON)AEON Biopharma, Inc. (NASDAQ:AEON - Free Report) - Equities researchers at HC Wainwright issued their Q1 2025 earnings estimates for AEON Biopharma in a report released on Wednesday, April 17th. HC Wainwright analyst D. Tsao expects that the company will post earnings per share of ($0.29) for theApril 17, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $18.00 price objective on shares of AEON Biopharma in a research report on Wednesday.March 30, 2024 | globenewswire.comCORRECTION -- AEON Biopharma Announces Redemption of Public WarrantsMarch 29, 2024 | globenewswire.comAEON Biopharma Announces Redemption of Public WarrantsMarch 29, 2024 | globenewswire.comAEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | seekingalpha.comLenz stock rallies 22% amid bullish note by Piper SandlerMarch 21, 2024 | investing.comAEON Biopharma secures $15 million in private placementMarch 20, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Shares Gap Down to $14.40AEON Biopharma (NASDAQ:AEON) Shares Gap Down to $14.40March 19, 2024 | globenewswire.comAEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of MigraineMarch 19, 2024 | globenewswire.comAEON Biopharma Announces $15 Million Financing Transaction and Termination of Forward Purchase AgreementsMarch 19, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Shares Down 7.2% AEON Biopharma (NASDAQ:AEON) Shares Down 7.2%March 18, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Reaches New 12-Month High at $15.98AEON Biopharma (NASDAQ:AEON) Sets New 52-Week High at $15.98March 15, 2024 | marketbeat.comAEON Biopharma (NASDAQ:AEON) Sees Strong Trading VolumeAEON Biopharma (NASDAQ:AEON) Sees Unusually-High Trading VolumeFebruary 26, 2024 | edition.cnn.comAEON Biopharma, Inc. Class AFebruary 6, 2024 | finanznachrichten.deDaewoong Pharmaceutical Co., Ltd.: Daewoong Pharmaceutical Announces 2023 Financial ResultsFebruary 1, 2024 | morningstar.comAeon Kyushu Co Ltd 2653January 31, 2024 | seekingalpha.comAEON.WS AEON Biopharma, Inc. WT EXP 072128January 18, 2024 | finance.yahoo.comAEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin ConferenceJanuary 10, 2024 | investing.comAeon Fantasy Co Ltd (4343)December 20, 2023 | morningstar.comXeris Biopharma Holdings Inc XERSDecember 12, 2023 | finance.yahoo.comAEON Biopharma Completes Enrollment in Phase 2 Study of ABP-450 (prabotulinumtoxinA) for Preventive Treatment of Chronic MigraineNovember 15, 2023 | finance.yahoo.comAEON Biopharma Inc Reports Q3 2023 Financial Results Amid Clinical AdvancementsNovember 14, 2023 | msn.comAEON Biopharma, Inc. GAAP EPS of -$0.04November 13, 2023 | finance.yahoo.comAEON Biopharma Reports Third Quarter 2023 Financial Results Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 Tech Stocks to Buy for 2024 (Ad)The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", AEON Media Mentions By Week AEON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEON News Sentiment▼0.000.76▲Average Medical News Sentiment AEON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEON Articles This Week▼01▲AEON Articles Average Week Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MRSN News FHTX News AQST News EPIX News QTTB News IMMP News ATAI News NKTR News VTYX News ALDX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEON) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored